AstraZeneca (United Kingdom)

AstraZeneca (United Kingdom)

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for AstraZeneca (United Kingdom), United Kingdom, covering academic research published from 2000 to 2021. Read More.


Open Access Percentage

45%


Total
Publications

22K


Total Open
Publications

10K


Total
Citations

802K


Open Access
Percentage

45%


Total
Publications

22K


Total Open
Publications

10K


Total
Citations

802K

Wikipedia

Website

Download

Breakdown

14% 22% 9% 55%

Publisher Open

14%

Both

22%

Other Platform Open

9%

Closed

55%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02004006008001k1.2k1.4k1.6k1.8kTotal Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021

Open

Closed

Publisher Open

31%OA Journal

OA Journal 31%

2.4K

Hybrid 42%

3.4K

No Guarantees 27%

2.2K

Other Platform Open

Domain 78%

5.3K

Institution 45%

3K

Public 11%

734

Preprint 5%

330

Other Internet 5%

329

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
5.3K
Europe PMC
Domain
4.1K
Semantic Scholar
Public
588
University College London - UCL Discovery
Institution
496
University of Cambridge - Apollo
Institution
303
The University of Manchester - Research Explorer
Institution
196
Imperial College London - Spiral
Institution
192
KTH Royal Institute of Technology - KTH Publication Database DiVA
Institution
176
whiterose.ac.uk OAI-PMH Repository
Institution
159
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
152
1 / 21

Data updated 27 September 2022

Share

Share

Share